Advancing
clinical
outcomes and
improving
patient quality
of life

WE ARE NOVA EYE MEDICAL

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

The iTrack is a tissue sparing minimally invasive glaucoma surgery that achieves excellent clinical outcomes while also preserving the viability of subsequent glaucoma treatments. Based on the principles of angioplasty, iTrack combines 360-degree catheterization with viscodilation to mechanically remove blockages and to dilate Schlemm’s canal in order to remove outflow resistance.

Visit the iTrack™ website
Glaucoma-iTrack.com

AlphaRET is a wholly owned subsidiary of Nova Eye Medical Limited, established to drive the commercial development of the 2RT™ project. 2RT™ is a breakthrough nano-pulse laser technology that stimulates the eye’s natural healing response to treat intermediate age-related macular degeneration (AMD), one of the world’s leading causes of blindness.
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More